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A B S T R A C T
Legionella longbeachae was cultured from the spu-
tum of a patient suffering from Legionnaires’
disease. Source identification efforts included
analysis of samples of potting soil from the
patient’s garden, and a genotypically indistin-
guishable strain of L. longbeachae was cultured
from this material. Following examination of a
national collection of Legionella isolates, two more
patients with indistinguishable genotypes were
identified. One of these patients had visited a
garden centre in the same municipality in which
the index patient had acquired his potting soil.
The study demonstrated the value of systematic
collection of identification data and patient iso-
lates over a prolonged period.
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Legionnaires’ disease (LD) is a pneumonia caused
by Legionella spp., predominantly (>90%) Legio-
nella pneumophila. Worldwide, the second most
Corresponding author and reprint requests: J. W. Den Boer,
Municipal Health Service Kennemerland, PO Box 5514, 2000
GM Haarlem, The Netherlands
E-mail: jwdenboer@hdk.nl
88 Clinical Microbiology and Infection, Volume 13 Number 1, January 2007
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 86–108
commonly isolated species is Legionella longbea-
chae [1]. In Australia, this species is responsible for
30% of reported cases of LD. The transmission of
this pathogen has been associated in Australia
and the USA with handling potting soil [2,3], but
to our knowledge, there have been no previous
reports of such an association in Europe.
In December 2004, the Dutch National Legio-
nella Outbreak Detection Programme (NLODP)
was informed of a patient with LD (date of onset, 4
November 2004). L. longbeachaewas cultured from
the sputum of the patient, who had died 2 weeks
following admission. A recent change in the Dutch
regulations, abandoning notification of LD caused
by species other than L. pneumophila, meant that
the patient had not been notified to the Ministry of
Health. An interviewwith the patient’s relatives in
December 2004 revealed that the patient, a male
who smoked cigarettes, aged 67 years, with no
known underlying disease, had been working in
his garden with commercial potting soil during
the week before his illness. On the basis of this
information, workers of the NLODP collected
water and biofilm samples from the patient’s
home, and potting soil samples from the patient’s
garden. All water and biofilm samples were
negative, but Legionella spp. were cultured from
the potting soil. Amplified fragment length poly-
morphism analysis [4] identified two distinct
genotypes, one belonging to L. pneumophila and
one to L. longbeachae. The DNA banding pattern of
the latter was indistinguishable from that of the
L. longbeachae isolate from the patient’s sputum
(Fig. 1, lanes 1 and 4). The other isolate was typed
as L. pneumophila serogroup 7-14.
The NLODP has access to data from all LD
patients who have been notified in The Nether-
lands since 1987, and a collection of 352 patient-
derived Legionella isolates. Although only five of
these isolates are L. longbeachae, a patient with LD
(date of disease onset, 7 August 2000) caused by
L. longbeachae had visited a garden centre during
his incubation period in the same community
where the index patient had obtained his potting
soil. The second patient, a non-smoking male aged
81 years, had no other underlying disease apart
from type 2 diabetes mellitus, and had not been
working in a garden or with potting soil. The DNA
banding pattern of the L. longbeachae isolate from
this patient’s sputum was indistinguishable from
that of the isolate from the index patient and the
potting soil (Fig. 1, lane 3). Also indistinguishable
was a further L. longbeachae DNA pattern for an
isolate from the sputum of an LD patient (date of
disease onset, 27 August 2000) (Fig. 1, lane 2) who
had been working with potting soil in his garden
during the incubation period. This patient lived
65 km from the index patient, making it unlikely
that he had used potting soil from the same garden
centre. The third patient was a non-smoking male,
aged 69 years, who had suffered for 5 years from
chronic lymphocytic leukaemia, for which he did
not use medication. The fourth and fifth L. long-
beachae isolates from the collection both showed
distinct DNA banding patterns (Fig. 1, lanes 5 and
6) and were unrelated to the three clustered
patient isolates.
Unfortunately, more precise information was
not available, since all three clustered patients died
following hospital admission. Aspiration of small
contaminated potting soil particles seems a rather
exotic explanation for transmission of L. longbea-
chae [5]. Aerosol-aided spread following air move-
ment and evaporation of water in potting soil
seems more likely, as this resembles waterborne
spread, in which aerosols are a vehicle that enables
legionellae to escape from the liquid environment.
Aerosols that can be inhaled by humans (<5 lm)
evaporate in milliseconds at standard environ-
mental air temperature and humidity [6]. This may
explain why the second patient, who did not
handle potting soil, still became infected.
During the last 3 years, six of the 37 clusters of
LD patients identified by the NLODP have been














Isolate from patient with date of onset 27 August, 2000
Isolate from patient with date of onset 7 August, 2000
Isolate from patient with date of onset 4 November, 2004 (index)
Isolate from unrelated patient
Isolate from unrelated patient
Reference strain ATCC 33462
Reference strain ATCC 33484
Fig. 1. Dendrogram of Legionella longbeachae isolates constructed using an amplified fragment length polymorphism assay.
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associated with garden centres, with no satisfac-
tory explanation. Although ten of the 12 patients
involved were diagnosed with L. pneumophila
infection (four culture-positive for serogroup 1,
and one culture-positive for serogroup 3), trans-
mission involving potting soil should not be ruled
out in view of the present finding of L. pneumo-
phila in the potting soil used by the index patient.
In Australia [2], but not in Japan [7], L. pneumo-
phila has been cultured from potting soils. In
addition, composted plant material should be
considered as a possible source of infection for
L. pneumophila. In Australia, all composted plant
material from large producers contained L. pneu-
mophila, although these belonged almost exclu-
sively to serogroup 2-14 [5]. More data are
required to evaluate the possible relevance of this
route of transmission in Europe. Two soil surveys
in Europe for L. longbeachae and L. pneumophila
have both been negative [2,8], but the present
study contradicts the earlier hypothesis that
potting soil in Europe is free of Legionella spp.
because its major component is peat, whereas
potting soils in Australia, Japan and the USA are
composed primarily of sawdust and bark [7].
Since August 2002, systematic sampling by the
NLODP of potential water sources in relation to
patients with LD has not yielded L. longbeachae,
but Legionella anisa was isolated from water
sources in two of the 22 garden centres sampled.
In Europe, 38 countries collaborating in the
European Working Group on Legionella Infec-
tions have agreed to use amplified fragment
length polymorphism typing for L. pneumophila
serogroup 1 [9], later followed by a more sophis-
ticated sequence-based typing scheme [10]. To
date, neither technique has been used for typing
L. longbeachae, but results with allozyme electro-
phoresis and restriction fragment length poly-
morphism analysis suggest that the L. longbeachae
isolates were closely related to each other and to
most of the Australian environmental strains [11].
Macrorestriction digestion with SfiI, followed by
pulsed-field gel electrophoresis, distinguished
three distinct pulsotypes with >65% similarity,
and 11 subgroups with >88% similarity [12]. The
amplified fragment length polymorphism assay is
preferred to pulsed-field gel electrophoresis [13]
by the European Working Group on Legionella
Infections for genotyping of L. pneumophila, but
the index of diversity for L. longbeachae requires
further investigation.
In conclusion, given the low incidence of LD
caused by L. longbeachae, the described cluster of
isolates is remarkable. It is clear that it is worth-
while sampling potential sources of infection for
LD caused by species other than L. pneumophila.
Furthermore, the results confirm the value of
systematic collection of notification data and
patient isolates over a prolonged period [14].
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A B S T R A C T
This study assessed the persistence of humoral
(neutralising antibody titre to vaccinia virus) and
cellular (immediate vaccinia-specific interferon
(IFN)-c-producing T-cell) immunities to smallpox
in a Korean population. Individuals who were
vaccinated 25–60 years previously had higher
neutralising antibody titres (geometric mean titre
(GMT) 13.7; 95% CI 11.0–17.2) than vaccinia-
naive individuals (GMT 6.7; 95% CI 5.5–8.0;
p <0.001). However, there was no significant
difference in cellular immunity between indivi-
duals vaccinated previously and vaccinia-naive
individuals, and only 15% of the individuals
vaccinated previously displayed an immediate
IFN-c-producing effector-memory response in
ELISPOT assays.
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This study assessed the persistence of humoral
(neutralising antibody titre to vaccinia virus) and
cellular (immediate vaccinia-specific interferon
(IFN)-c-producing T-cell) immunities to smallpox
among healthy Korean adults.
Sera and peripheral blood mononuclear cells
(PBMCs) were obtained from healthy volunteers,
aged 20–60 years, between January 2003 and
December 2004. PBMCs were isolated within 6 h
of sample collection, using Ficoll-Hypaque den-
sity gradients, and were cryopreserved. Neutral-
isation antibody assays were performed as
described previously [1–3]. Cell-mediated im-
mune responses to smallpox vaccination were
assessed as immediate vaccinia-specific IFN-c-
producing T-cell response by ELISPOT assays.
The detailed protocol has been described previ-
ously [3]. Spots were scored as positive if there
were ‡20 vaccinia-specific spot-forming cells
(SFCs) ⁄million PBMCs (after subtracting the back-
ground obtained with unstimulated cells). This
threshold for positivity was established after
taking into account the variability of the back-
ground obtained with cells alone (mean ± stand-
ard deviation (SD), 9.5 ± 11.1 SFCs ⁄ 106 PBMCs;
range 0–58) and the SFC range among 16 vaccinia-
naive individuals used as negative controls
(median 1.2 SFCs ⁄ 106 PBMCs; range 0–
19 SFCs ⁄ 106 PBMCs).
Eighty-three volunteers participated in the
study. The mean age (±SD) of the subjects was
33.1 years (±7.3 years), and 66 (80%) were male.
Of the 83 participating individuals, 63 (76%) had
a history of smallpox vaccination or a scar from
vaccinia vaccination, and 20 (24%) were vaccinia-
naive. Neutralising antibody titres were signifi-
cantly higher among the individuals vaccinated
previously (geometric mean titre (GMT) 13.7;
95% CI 11.0–17.2) than among the vaccinia-naive
individuals (GMT 6.7; 95% CI 5.5–8.0; p <0.001).
PBMCs were obtained successfully from 55
(66%) subjects, of whom 39 (71%) had been
vaccinated previously and 16 (29%) were vacci-
nia-naive. Only 15% (6 ⁄ 39) of the previously
vaccinated subjects in this population displayed
an immediate IFN-c-producing effector-memory
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